Sickle-cell Anemia Therapeutics Market
Sickle-cell Anemia Therapeutics Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
Sickle-cell Anemia Therapeutics Market Size and Growth
The global Sickle-cell Anemia Therapeutics market is projected to grow significantly due to increasing prevalence of the disease. Market research reports indicate a promising future for key players in the industry. The market size is estimated to be worth billions of dollars, with growth opportunities in various regions.
Companies Covered
(Covid 19 Impact Covered)
◍ Addmedica
◍ Gamida Cell
◍ GlycoMimetics
◍ Pfizer
◍ Novartis
◍ Global Blood Therapeutics
◍ Micelle BioPharma
◍ Bluebird Bio
◍ Prolong Pharmaceuticals
◍ Modus Therapeutics
◍ Sangamo Biosciences
◍ Bioverativ
◍ Imara
◍ Ironwood Pharmaceuticals
Competitive landscape of sickle-cell anemia therapeutics market includes companies like Addmedica, Gamida Cell, GlycoMimetics, Pfizer, Novartis, Global Blood Therapeutics, Micelle BioPharma, Bluebird Bio, Prolong Pharmaceuticals, Modus Therapeutics, Sangamo Biosciences, Bioverativ, Imara, Ironwood Pharmaceuticals.
These companies develop various therapeutics targeting sickle-cell anemia, such as gene therapies, small molecules, and stem cell transplants. They contribute to the growth of the market by providing innovative treatment options, conducting clinical trials, and partnering with other companies for research and development.
- Pfizer: $52.5 billion
- Novartis: $47.45 billion
- Bluebird Bio: $579.3 million
Request Sample Report
Market Segmentation
By Application
Child
Adult
Request Sample Report
By Product
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant
Market Growth
Request Sample Report
$ X Billion USD
